The impact of duration of treatment on reported time-to-onset in spontaneous reporting systems for pharmacovigilance.
Within pharmacovigilance, knowledge of time-to-onset (time from start of drug administration to onset of reaction) is important in causality assessment of drugs and suspected adverse drug reactions (ADRs) and may indicate pharmacological mechanisms involved. It has been suggested that time-to-onset...
Enregistré dans:
Auteurs principaux: | Ghazaleh Karimi, Kristina Star, G Niklas Norén, Staffan Hägg |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a5a773b0971f442988c68a22cfee43a7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Quality assessment of individual case safety reports in pharmacovigilance in Burkina Faso
par: Roamba Nazaire, et autres
Publié: (2021) -
Pharmacovigilance in Covid-19 vaccines
par: Bahouq Hanane, et autres
Publié: (2021) -
Pharmacovigilance of quality deviations in the public healthcare system
par: Carolina Resende Bitencourt, et autres
Publié: (2019) -
Gathering and exploring scientific knowledge in pharmacovigilance.
par: Pedro Lopes, et autres
Publié: (2013) -
A pharmacovigilance study of association between proton pump inhibitor and dementia event based on FDA adverse event reporting system data
par: Bin Wu, et autres
Publié: (2021)